Evaluation of NICOM (Bioreactance) for the Non-invasive Determination of Cardiac Output
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Universitätsmedizin Mannheim
- Enrollment
- 41
- Primary Endpoint
- agreement of NICOM and MRT cardiac output measurements
Study Overview
Brief Summary
Cardiac output (CO) is an important parameter in the diagnosis and therapy of cardiac diseases. The current standard methods for the determination of CO, however, are either invasive (e.g. right heart catheterization) or technically expendable and expensive (magnetic resonance tomography, MRT). Therefore, the aim of the study at hand was to evaluate NICOM (bioreactance) as a new method for determinion of CO and to compare this new technique to MRT.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •indication for cardiac magnetic resonance imaging
Exclusion Criteria
- •pace maker
- •patient unwilling to participate
Outcomes
Primary Outcomes
agreement of NICOM and MRT cardiac output measurements
Time Frame: at time of inclusion
precision of NICOM cardiac output measurements
Time Frame: at time of inclusion
Secondary Outcomes
No secondary outcomes reported
Investigators
Joachim Saur
senior physician
Universitätsmedizin Mannheim
